Estrella Immunopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 23, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	37	43	38	19	-	-
Market Cap Growth	11.11%	13.67%	101.23%	-	-	-
Enterprise Value	36	42	33	21	-	-
Last Close Price	1.02	1.20	1.05	10.84	10.00	-
PB Ratio	256.84	302.06	8.94	-2.81	-	-
P/TBV Ratio	256.63	302.06	8.94	-	-	-
Debt / Equity Ratio	0.03	0.03	0.00	0.00	-	-
Quick Ratio	0.31	0.31	23.05	0.25	4.32	-
Current Ratio	0.55	0.55	24.65	0.28	5.20	-
Return on Assets (ROA)	-	-	-122.12%	-174.75%	-	-
Earnings Yield	-24.00%	-20.39%	-19.14%	-58.56%	-	-
Buyback Yield / Dilution	-255.55%	-34.73%	-8764.81%	-	-	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q